课题基金 / 基金详情

Implication of hepatic sinusoidal cells in pathophysiology of the liver diseases and development of novel therapeutic strategies

Implication of hepatic sinusoidal cells in pathophysiology of the liver diseases and development of novel therapeutic strategies
肝窦细胞在肝脏疾病病理生理学中的意义及新治疗策略的开发
批准号:
06454383
负责人:
ARII Shigeki
金额:
$4.61万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

ARII Shigeki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Mechanism on endotoxin-induced liver injury. We clarified that ICAM-1 expression in the hepatic sinusoidal endothelial cell (SEC) was increased and then such increase was inhibited by a blockade of hepatic macrophages in endotoxin-injected rats. Also, we showed the amelioration of endotoxin-induced liver injury in the leucocytes-depletion rats. These evidence suggested the causative role of the interaction among hepatic macrophage, adhesion molecule and leucocytes in this injury. Furthermore, we identified thromboxane (TX) A_2 receptor (R) on SEC and showed pathogenic implication of TXA_2-TXA_2R system in endotoxin-induced and cold preservation/reperfusion liver injury.2. Pathogenesis of cold preservation-reperfusion liver injury. We found that hepatic macrophage is at priming state in the cold preservation of the liver. Then, it was shown that a blockade of hepatic macrophage suppressed intrasinusoidal coagulation and leucocyte adhesion in the liver, leading to the inhibition of hepatic microcirculatory disturbance.3. Expression of the Na^+/Ca^<++> exchanger in activated Ito cells. We demonstrated first that Na^+/Ca^<++> exchanger, which is a transporter protein that couples the translocation of Ca^<++> to that of Na^+ in the opposite direction and contribute to the maintenance of intracelluler Ca^<++> homeostasis, is expressed in Ito cells in association with liver fibrosis.4. Identification of kan-1 and its clinical implication. We identified a novel gene, kan-1 in the rat liver using an RNA-PCR cloning strategy. By cross-hybridyzation with a rat kan-1 cDNA probe, we obtained a cDNA clone from a human liver cDNA library. This is found to be identical to bile acid CoA : amino acid N-acyltransferase. We showed that kan-1 is a novel predictive indicator for prognosis of hepatoma patients.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Arii S: "Pathogenic role of kapffer cell actioation in the reperfusion injury of cold-presesved bieer" Transplantation. 58. 1072-1077 (1994)
Arii S:“卡普弗细胞激活在冷保存啤酒再灌注损伤中的致病作用”移植。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shigeki Arii: "Chemical mediators release and surface marker expression of hepatic macrophages in rats with CC14-induced liver cirrhosis." Life Sciences. 54. 2071-2082 (1994)
Shigeki Arii:“CC14 诱导的肝硬化大鼠肝巨噬细胞的化学介质释放和表面标志物表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Furutani M et al: "Immunological activation of hepatic macrophages in septic rats : a possible mechanism of sepsic-associated liver injury" J.Lab.Clin.Med.123. 430-435 (1994)
Furutani M 等人:“脓毒症大鼠肝巨噬细胞的免疫激活:脓毒症相关肝损伤的可能机制”J.Lab.Clin.Med.123。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Study on the molecular diagnosis of metastasis and recurrence and molecular targeted therapy for intractable hepato-pancreatic cancer
    • 批准号:
      20249061
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.87万
    • 财政年份:
      2008
    • 负责人:
      ARII Shigeki
    • 依托单位:
    Multidisciplinary research for molecular mechanism of cancer progression and development of diagnostic and therapeutic tool
    • 批准号:
      18209043
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.03万
    • 财政年份:
      2006
    • 负责人:
      ARII Shigeki
    • 依托单位:
    Development of molecular- targeting therapy and prediction of mode of recurrence by analysis of molecular mechanism of invasion and metastasis of hepatocellular carcinoma
    • 批准号:
      16390375
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2004
    • 负责人:
      ARII Shigeki
    • 依托单位:
    Order-made medicine for cancer in the viewpoint of angiogenesis
    • 批准号:
      14370379
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.34万
    • 财政年份:
      2002
    • 负责人:
      ARII Shigeki
    • 依托单位:
    海外基金